FY2024 Earnings Forecast for BioRem Issued By Cormark

BioRem Inc. (CVE:BRM) – Equities researchers at Cormark issued their FY2024 earnings per share (EPS) estimates for BioRem in a research note issued on Tuesday, December 17th. Cormark analyst N. Boychuk anticipates that the company will post earnings of $0.19 per share for the year. Cormark has a “Moderate Buy” rating on the stock. Cormark also issued estimates for BioRem’s FY2025 earnings at $0.22 EPS and FY2026 earnings at $0.29 EPS.

BioRem Price Performance

Shares of BRM stock opened at C$3.14 on Friday. The company has a debt-to-equity ratio of 48.97, a quick ratio of 1.08 and a current ratio of 1.57. BioRem has a 52-week low of C$0.95 and a 52-week high of C$3.39. The firm’s 50 day moving average price is C$2.84 and its two-hundred day moving average price is C$2.41. The stock has a market cap of C$49.30 million, a PE ratio of 14.95 and a beta of 0.85.

Insider Buying and Selling at BioRem

In other news, Director Derek Webb sold 120,000 shares of BioRem stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of C$2.93, for a total value of C$351,600.00. Insiders own 1.90% of the company’s stock.

BioRem Company Profile

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.